Bon Natural Life
BON
0 hedge funds and large institutions have $0 invested in Bon Natural Life in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
26.78% less ownership
Funds ownership: 26.78% → 0% (-27%)
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $36.7K → $0 (-$36.7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$19K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$16.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.5K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| – | -$19K | -15,337 | Closed |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$16.1K | -12,920 | Closed |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| – | -$1.5K | -1,202 | Closed |
|
|
4
Raymond James Financial
St Petersburg,
Florida
| – | -$1 | -1 | Closed |
|
BON Hedge Fund Activity: Q3 2025 in Review
0 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Bon Natural Life (BON) for Q3 2025, worth a combined $0 — down 100% from $36.7K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BON and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was HRT Financial, exiting entirely with an estimated $19K sold.
- 0 institutional investors held Bon Natural Life (BON) as of Q3 2025, down from 4 in Q2 2025.
- Funds reported $0 of Bon Natural Life stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new Bon Natural Life positions in Q3 2025 and 4 closed out, a net change of -4 holders.
- The largest Bon Natural Life seller in Q3 2025 was HRT Financial, an estimated $19K sold.
Based on aggregated 13F filings for Q3 2025.